

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 7.83488429 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 7.56228286 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.38144469 |
| 4 | positive regulation of synapse maturation (GO:0090129) | 6.35482982 |
| 5 | succinate metabolic process (GO:0006105) | 6.17432691 |
| 6 | neurotransmitter-gated ion channel clustering (GO:0072578) | 6.16083279 |
| 7 | startle response (GO:0001964) | 5.92012962 |
| 8 | gamma-aminobutyric acid transport (GO:0015812) | 5.73752706 |
| 9 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.64001855 |
| 10 | regulation of synapse maturation (GO:0090128) | 5.50224309 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.49052593 |
| 12 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 5.39440218 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.18988615 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.15711041 |
| 15 | protein localization to synapse (GO:0035418) | 5.10820009 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.05735936 |
| 17 | cell migration in hindbrain (GO:0021535) | 5.04574673 |
| 18 | neurotransmitter secretion (GO:0007269) | 5.03769806 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.02209299 |
| 20 | nucleobase catabolic process (GO:0046113) | 5.00763588 |
| 21 | auditory behavior (GO:0031223) | 4.83312248 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.72913441 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 4.72323098 |
| 24 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.71055345 |
| 25 | proline transport (GO:0015824) | 4.46920356 |
| 26 | positive regulation of synapse assembly (GO:0051965) | 4.36840873 |
| 27 | establishment of mitochondrion localization (GO:0051654) | 4.34164193 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 4.32016338 |
| 29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.31367065 |
| 30 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 4.29784511 |
| 31 | transferrin transport (GO:0033572) | 4.23803044 |
| 32 | striatum development (GO:0021756) | 4.23516356 |
| 33 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.22838633 |
| 34 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.22838633 |
| 35 | presynaptic membrane assembly (GO:0097105) | 4.18904015 |
| 36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.16670376 |
| 37 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.15069674 |
| 38 | dendrite morphogenesis (GO:0048813) | 4.12628866 |
| 39 | response to auditory stimulus (GO:0010996) | 4.12188893 |
| 40 | protein-cofactor linkage (GO:0018065) | 4.11123586 |
| 41 | postsynaptic membrane organization (GO:0001941) | 4.01631320 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.01342903 |
| 43 | limb bud formation (GO:0060174) | 4.00757605 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.99741122 |
| 45 | trivalent inorganic cation transport (GO:0072512) | 3.99433304 |
| 46 | ferric iron transport (GO:0015682) | 3.99433304 |
| 47 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.98257219 |
| 48 | dendritic spine morphogenesis (GO:0060997) | 3.98170011 |
| 49 | synaptic vesicle maturation (GO:0016188) | 3.97142512 |
| 50 | neurotransmitter transport (GO:0006836) | 3.96641977 |
| 51 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.95840465 |
| 52 | locomotory exploration behavior (GO:0035641) | 3.93849693 |
| 53 | positive regulation of action potential (GO:0045760) | 3.93033955 |
| 54 | mechanosensory behavior (GO:0007638) | 3.89525822 |
| 55 | long-term synaptic potentiation (GO:0060291) | 3.83611083 |
| 56 | regulation of synaptic vesicle transport (GO:1902803) | 3.82409288 |
| 57 | cerebellar granule cell differentiation (GO:0021707) | 3.81067649 |
| 58 | presynaptic membrane organization (GO:0097090) | 3.77226516 |
| 59 | behavioral response to cocaine (GO:0048148) | 3.74152792 |
| 60 | prostate gland growth (GO:0060736) | 3.72735776 |
| 61 | neuron recognition (GO:0008038) | 3.69465776 |
| 62 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.69450790 |
| 63 | mitochondrion transport along microtubule (GO:0047497) | 3.69450790 |
| 64 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.64581032 |
| 65 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.64558039 |
| 66 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.64014904 |
| 67 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.64011637 |
| 68 | dicarboxylic acid catabolic process (GO:0043649) | 3.63095132 |
| 69 | synaptic transmission, glutamatergic (GO:0035249) | 3.62123897 |
| 70 | detection of calcium ion (GO:0005513) | 3.61722988 |
| 71 | positive regulation of amino acid transport (GO:0051957) | 3.61506664 |
| 72 | regulation of axon guidance (GO:1902667) | 3.61476288 |
| 73 | central nervous system neuron axonogenesis (GO:0021955) | 3.59436575 |
| 74 | exploration behavior (GO:0035640) | 3.59184988 |
| 75 | regulation of neurotransmitter levels (GO:0001505) | 3.57084975 |
| 76 | glutamate secretion (GO:0014047) | 3.51062709 |
| 77 | positive regulation of membrane potential (GO:0045838) | 3.50647224 |
| 78 | learning (GO:0007612) | 3.48090525 |
| 79 | synapse assembly (GO:0007416) | 3.47565992 |
| 80 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.45121428 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.44510534 |
| 82 | nerve growth factor signaling pathway (GO:0038180) | 3.44368135 |
| 83 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.43439544 |
| 84 | regulation of glutamate secretion (GO:0014048) | 3.41819214 |
| 85 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.39639043 |
| 86 | membrane assembly (GO:0071709) | 3.36047556 |
| 87 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.34859726 |
| 88 | maternal behavior (GO:0042711) | 3.32860709 |
| 89 | positive regulation of dendritic spine development (GO:0060999) | 3.32784837 |
| 90 | response to histamine (GO:0034776) | 3.32741509 |
| 91 | long-term memory (GO:0007616) | 3.32546785 |
| 92 | neurotransmitter biosynthetic process (GO:0042136) | 3.31802781 |
| 93 | neuronal ion channel clustering (GO:0045161) | 3.31353615 |
| 94 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.29317423 |
| 95 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26325209 |
| 96 | regulation of synapse assembly (GO:0051963) | 3.26075003 |
| 97 | glycerophospholipid catabolic process (GO:0046475) | 3.26037681 |
| 98 | multicellular organismal reproductive behavior (GO:0033057) | 3.24616458 |
| 99 | regulation of female receptivity (GO:0045924) | 3.24585437 |
| 100 | axon extension (GO:0048675) | 3.23223307 |
| 101 | retinal ganglion cell axon guidance (GO:0031290) | 3.23048562 |
| 102 | social behavior (GO:0035176) | 3.22148680 |
| 103 | intraspecies interaction between organisms (GO:0051703) | 3.22148680 |
| 104 | regulation of synaptic plasticity (GO:0048167) | 3.20532808 |
| 105 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.20332846 |
| 106 | * response to cocaine (GO:0042220) | 3.20298082 |
| 107 | neuron migration (GO:0001764) | 3.20210876 |
| 108 | neuron fate determination (GO:0048664) | 3.18962492 |
| 109 | female mating behavior (GO:0060180) | 3.18085958 |
| 110 | * regulation of synaptic transmission, GABAergic (GO:0032228) | 3.14540134 |
| 111 | regulation of postsynaptic membrane potential (GO:0060078) | 3.13555027 |
| 112 | regulation of protein kinase A signaling (GO:0010738) | 3.13403973 |
| 113 | behavioral response to nicotine (GO:0035095) | 3.13248919 |
| 114 | neurotransmitter metabolic process (GO:0042133) | 3.13041517 |
| 115 | axonal fasciculation (GO:0007413) | 3.11803700 |
| 116 | short-term memory (GO:0007614) | 3.11467402 |
| 117 | glutamate receptor signaling pathway (GO:0007215) | 3.10739054 |
| 118 | transmission of nerve impulse (GO:0019226) | 3.10163637 |
| 119 | cerebral cortex cell migration (GO:0021795) | 3.09465518 |
| 120 | synaptic vesicle endocytosis (GO:0048488) | 3.08216138 |
| 121 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.06985092 |
| 122 | negative regulation of dendrite development (GO:2000171) | 3.06937609 |
| 123 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.06673937 |
| 124 | * regulation of penile erection (GO:0060405) | 3.04243234 |
| 125 | phagosome maturation (GO:0090382) | 3.03784544 |
| 126 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.03663200 |
| 127 | neuromuscular synaptic transmission (GO:0007274) | 3.03111858 |
| 128 | behavioral defense response (GO:0002209) | 3.03023418 |
| 129 | behavioral fear response (GO:0001662) | 3.03023418 |
| 130 | serotonin receptor signaling pathway (GO:0007210) | 3.00715420 |
| 131 | regulation of dendritic spine development (GO:0060998) | 3.00340802 |
| 132 | axonogenesis (GO:0007409) | 2.99715572 |
| 133 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.98861349 |
| 134 | positive regulation of muscle hypertrophy (GO:0014742) | 2.98861349 |
| 135 | negative regulation of neurotransmitter transport (GO:0051589) | 2.96897106 |
| 136 | visual learning (GO:0008542) | 2.96847737 |
| 137 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.96800723 |
| 138 | regulation of respiratory system process (GO:0044065) | 2.96794222 |
| 139 | synapse organization (GO:0050808) | 2.96524356 |
| 140 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.94567880 |
| 141 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.89123551 |
| 142 | membrane depolarization during action potential (GO:0086010) | 2.88721526 |
| 143 | negative regulation of axon extension (GO:0030517) | 2.84953512 |
| 144 | membrane depolarization (GO:0051899) | 2.84522809 |
| 145 | regulation of synapse organization (GO:0050807) | 2.83779125 |
| 146 | neuron projection extension (GO:1990138) | 2.79200746 |
| 147 | regulation of dendrite morphogenesis (GO:0048814) | 2.78910748 |
| 148 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.78083263 |
| 149 | negative regulation of axonogenesis (GO:0050771) | 2.76130598 |
| 150 | organelle transport along microtubule (GO:0072384) | 2.76043242 |
| 151 | regulation of axon extension (GO:0030516) | 2.75458580 |
| 152 | regulation of dendrite development (GO:0050773) | 2.75333798 |
| 153 | cellular potassium ion homeostasis (GO:0030007) | 2.74871429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.40239224 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 5.12902505 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.26906016 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.96253243 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91054038 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.80773891 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.80497981 |
| 8 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66994792 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.66506962 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.48766482 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45588464 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.40968651 |
| 13 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.34677395 |
| 14 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34636245 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.24898985 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.23767743 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23001238 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23001238 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.22619088 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.16477642 |
| 21 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15005934 |
| 22 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14344005 |
| 23 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07442412 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07101203 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06787195 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 2.05691990 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.03499351 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.03044747 |
| 29 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96438388 |
| 30 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.91713278 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 1.90214750 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88085238 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.84342646 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83759963 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81860795 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.81815881 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.77259328 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75960562 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.72078283 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71988524 |
| 41 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.70739498 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68691076 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67463357 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67041958 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.61498849 |
| 46 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.58645950 |
| 47 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57892775 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57595209 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56009856 |
| 50 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55950566 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52056393 |
| 52 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51077389 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.49926390 |
| 54 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49181213 |
| 55 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48850330 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.48850330 |
| 57 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43737228 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40802648 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40254953 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35745863 |
| 61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.34871279 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34613382 |
| 63 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34594268 |
| 64 | JUN_21703547_ChIP-Seq_K562_Human | 1.31954372 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30389354 |
| 66 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.29208035 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28890893 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26614711 |
| 69 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26014178 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25570626 |
| 71 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25226201 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23965309 |
| 73 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23311378 |
| 74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22542142 |
| 75 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20207377 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19481822 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.19377794 |
| 78 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19103261 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18620386 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17964387 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16531981 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16322571 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16189844 |
| 84 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.15873095 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14446568 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13626670 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12012463 |
| 88 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11109518 |
| 89 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11040585 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09192054 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08743930 |
| 92 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07745613 |
| 93 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07564674 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07375125 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07375125 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05930940 |
| 97 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05263300 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05127714 |
| 99 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04695151 |
| 100 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04483694 |
| 101 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03951646 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03565940 |
| 103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03310480 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03045510 |
| 105 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02997018 |
| 106 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.02746413 |
| 107 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01040308 |
| 108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00917473 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00484632 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00357505 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98589502 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97599485 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97556255 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96818681 |
| 115 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95272525 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94527786 |
| 117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94456490 |
| 118 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94360954 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93815226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.81215592 |
| 2 | MP0009046_muscle_twitch | 3.88062187 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.86513869 |
| 4 | * MP0009745_abnormal_behavioral_response | 3.71171485 |
| 5 | * MP0002064_seizures | 3.61914050 |
| 6 | MP0003880_abnormal_central_pattern | 3.35424502 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.24705919 |
| 8 | * MP0002572_abnormal_emotion/affect_behav | 2.98149880 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.95277479 |
| 10 | MP0003787_abnormal_imprinting | 2.83752296 |
| 11 | MP0002272_abnormal_nervous_system | 2.69400135 |
| 12 | MP0001486_abnormal_startle_reflex | 2.58073854 |
| 13 | MP0001188_hyperpigmentation | 2.40560382 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.37568480 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.36130556 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.33944915 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.32490097 |
| 18 | MP0006276_abnormal_autonomic_nervous | 2.29789650 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.29006897 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.24729241 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.20762035 |
| 22 | MP0002736_abnormal_nociception_after | 2.17073036 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.11743109 |
| 24 | * MP0002735_abnormal_chemical_nociception | 2.11422526 |
| 25 | MP0004270_analgesia | 2.05800378 |
| 26 | MP0002184_abnormal_innervation | 2.01621928 |
| 27 | MP0001984_abnormal_olfaction | 2.00861630 |
| 28 | MP0010386_abnormal_urinary_bladder | 1.95332928 |
| 29 | MP0003122_maternal_imprinting | 1.92859601 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.88919353 |
| 31 | MP0008569_lethality_at_weaning | 1.85298780 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.83888091 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.79800581 |
| 34 | MP0003329_amyloid_beta_deposits | 1.67301649 |
| 35 | MP0000778_abnormal_nervous_system | 1.66287424 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.61561782 |
| 37 | * MP0001970_abnormal_pain_threshold | 1.54496006 |
| 38 | MP0004142_abnormal_muscle_tone | 1.52380788 |
| 39 | MP0004885_abnormal_endolymph | 1.51616115 |
| 40 | * MP0004811_abnormal_neuron_physiology | 1.51177463 |
| 41 | MP0005187_abnormal_penis_morphology | 1.49464222 |
| 42 | * MP0002066_abnormal_motor_capabilities/c | 1.45301915 |
| 43 | MP0002102_abnormal_ear_morphology | 1.44220948 |
| 44 | MP0005171_absent_coat_pigmentation | 1.44013386 |
| 45 | MP0003879_abnormal_hair_cell | 1.39338458 |
| 46 | MP0001529_abnormal_vocalization | 1.36593372 |
| 47 | MP0002751_abnormal_autonomic_nervous | 1.32917894 |
| 48 | MP0003136_yellow_coat_color | 1.32024731 |
| 49 | MP0001177_atelectasis | 1.30337921 |
| 50 | * MP0005386_behavior/neurological_phenoty | 1.30308472 |
| 51 | * MP0004924_abnormal_behavior | 1.30308472 |
| 52 | MP0000955_abnormal_spinal_cord | 1.27338816 |
| 53 | * MP0002882_abnormal_neuron_morphology | 1.26367732 |
| 54 | * MP0003861_abnormal_nervous_system | 1.25056453 |
| 55 | * MP0002733_abnormal_thermal_nociception | 1.20961482 |
| 56 | MP0001905_abnormal_dopamine_level | 1.20797049 |
| 57 | MP0003121_genomic_imprinting | 1.19694925 |
| 58 | MP0003890_abnormal_embryonic-extraembry | 1.18176411 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.16286118 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.16152695 |
| 61 | MP0003632_abnormal_nervous_system | 1.13568177 |
| 62 | * MP0002822_catalepsy | 1.13495642 |
| 63 | MP0003123_paternal_imprinting | 1.12677049 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.11541998 |
| 65 | MP0004147_increased_porphyrin_level | 1.11219008 |
| 66 | MP0001270_distended_abdomen | 1.10673266 |
| 67 | MP0004085_abnormal_heartbeat | 1.10370732 |
| 68 | MP0005394_taste/olfaction_phenotype | 1.09928273 |
| 69 | MP0005499_abnormal_olfactory_system | 1.09928273 |
| 70 | MP0000534_abnormal_ureter_morphology | 1.08437486 |
| 71 | MP0003631_nervous_system_phenotype | 1.07874179 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.07572654 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.05313527 |
| 74 | MP0006292_abnormal_olfactory_placode | 1.05263798 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.03409248 |
| 76 | * MP0002152_abnormal_brain_morphology | 1.02632309 |
| 77 | MP0002638_abnormal_pupillary_reflex | 1.02245558 |
| 78 | MP0003633_abnormal_nervous_system | 1.01475500 |
| 79 | MP0005248_abnormal_Harderian_gland | 1.01014426 |
| 80 | MP0000751_myopathy | 0.98163424 |
| 81 | * MP0002069_abnormal_eating/drinking_beha | 0.97442346 |
| 82 | MP0000604_amyloidosis | 0.89193936 |
| 83 | MP0002081_perinatal_lethality | 0.87659731 |
| 84 | MP0002653_abnormal_ependyma_morphology | 0.86791243 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 0.84657143 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.84524386 |
| 87 | MP0001664_abnormal_digestion | 0.84203282 |
| 88 | MP0005645_abnormal_hypothalamus_physiol | 0.84157066 |
| 89 | MP0002229_neurodegeneration | 0.83669301 |
| 90 | MP0003938_abnormal_ear_development | 0.81920969 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.80792574 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.80685071 |
| 93 | MP0000516_abnormal_urinary_system | 0.80685071 |
| 94 | MP0003283_abnormal_digestive_organ | 0.78635183 |
| 95 | MP0000049_abnormal_middle_ear | 0.78180840 |
| 96 | MP0005195_abnormal_posterior_eye | 0.77337162 |
| 97 | MP0004484_altered_response_of | 0.76495312 |
| 98 | MP0003646_muscle_fatigue | 0.75373418 |
| 99 | MP0002233_abnormal_nose_morphology | 0.74919817 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.74800548 |
| 101 | MP0004043_abnormal_pH_regulation | 0.74637922 |
| 102 | MP0004742_abnormal_vestibular_system | 0.74096912 |
| 103 | * MP0010769_abnormal_survival | 0.73599222 |
| 104 | MP0004133_heterotaxia | 0.73250697 |
| 105 | MP0001502_abnormal_circadian_rhythm | 0.72810218 |
| 106 | MP0002234_abnormal_pharynx_morphology | 0.72100215 |
| 107 | MP0000026_abnormal_inner_ear | 0.71524140 |
| 108 | MP0004233_abnormal_muscle_weight | 0.70808116 |
| 109 | MP0001299_abnormal_eye_distance/ | 0.70647898 |
| 110 | * MP0010768_mortality/aging | 0.69941896 |
| 111 | MP0005253_abnormal_eye_physiology | 0.69823481 |
| 112 | * MP0002082_postnatal_lethality | 0.69331911 |
| 113 | * MP0010770_preweaning_lethality | 0.69331911 |
| 114 | MP0003755_abnormal_palate_morphology | 0.69131243 |
| 115 | MP0000537_abnormal_urethra_morphology | 0.69089158 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.68811511 |
| 117 | MP0008874_decreased_physiological_sensi | 0.68150427 |
| 118 | MP0003119_abnormal_digestive_system | 0.67979375 |
| 119 | MP0003690_abnormal_glial_cell | 0.67316977 |
| 120 | MP0003634_abnormal_glial_cell | 0.67223414 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.67081984 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.66911703 |
| 123 | MP0000647_abnormal_sebaceous_gland | 0.66045833 |
| 124 | MP0000631_abnormal_neuroendocrine_gland | 0.65021630 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.64868150 |
| 126 | MP0001943_abnormal_respiration | 0.64100573 |
| 127 | MP0000681_abnormal_thyroid_gland | 0.62633745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.49571062 |
| 2 | Hyperventilation (HP:0002883) | 8.02670672 |
| 3 | Atonic seizures (HP:0010819) | 6.37718882 |
| 4 | Febrile seizures (HP:0002373) | 5.59680602 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.19477927 |
| 6 | Progressive inability to walk (HP:0002505) | 4.99199672 |
| 7 | Focal seizures (HP:0007359) | 4.79691541 |
| 8 | Absence seizures (HP:0002121) | 4.43105416 |
| 9 | Dialeptic seizures (HP:0011146) | 4.18627322 |
| 10 | Abnormal hair whorl (HP:0010721) | 3.94095578 |
| 11 | Broad-based gait (HP:0002136) | 3.72710327 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.54106870 |
| 13 | Inability to walk (HP:0002540) | 3.45720458 |
| 14 | Protruding tongue (HP:0010808) | 3.35874198 |
| 15 | Visual hallucinations (HP:0002367) | 3.33318253 |
| 16 | Gait imbalance (HP:0002141) | 3.31449091 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.28146689 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 3.23261859 |
| 19 | Absent speech (HP:0001344) | 3.20988768 |
| 20 | Abnormal social behavior (HP:0012433) | 3.16488914 |
| 21 | Impaired social interactions (HP:0000735) | 3.16488914 |
| 22 | Medial flaring of the eyebrow (HP:0010747) | 3.14697425 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.13511451 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.12717250 |
| 25 | Myokymia (HP:0002411) | 3.10823264 |
| 26 | Action tremor (HP:0002345) | 3.07302080 |
| 27 | Hemiparesis (HP:0001269) | 3.06645168 |
| 28 | Polyphagia (HP:0002591) | 3.06487534 |
| 29 | Congenital primary aphakia (HP:0007707) | 3.05916165 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.99375978 |
| 31 | Abnormality of binocular vision (HP:0011514) | 2.99171344 |
| 32 | Diplopia (HP:0000651) | 2.99171344 |
| 33 | Megalencephaly (HP:0001355) | 2.97174703 |
| 34 | Abnormality of the corticospinal tract (HP:0002492) | 2.90072092 |
| 35 | Truncal ataxia (HP:0002078) | 2.89940860 |
| 36 | Excessive salivation (HP:0003781) | 2.89771855 |
| 37 | Drooling (HP:0002307) | 2.89771855 |
| 38 | Progressive macrocephaly (HP:0004481) | 2.87769338 |
| 39 | Poor suck (HP:0002033) | 2.84027330 |
| 40 | Resting tremor (HP:0002322) | 2.82284611 |
| 41 | Nephrogenic diabetes insipidus (HP:0009806) | 2.80990939 |
| 42 | Blue irides (HP:0000635) | 2.80269475 |
| 43 | Poor eye contact (HP:0000817) | 2.78227013 |
| 44 | Spastic diplegia (HP:0001264) | 2.70949966 |
| 45 | Lissencephaly (HP:0001339) | 2.70441863 |
| 46 | Urinary urgency (HP:0000012) | 2.70219460 |
| 47 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.66410481 |
| 48 | Fair hair (HP:0002286) | 2.65729602 |
| 49 | Pheochromocytoma (HP:0002666) | 2.65602843 |
| 50 | Hepatoblastoma (HP:0002884) | 2.63691566 |
| 51 | Thickened helices (HP:0000391) | 2.62557832 |
| 52 | Pachygyria (HP:0001302) | 2.59579936 |
| 53 | Abnormality of the labia minora (HP:0012880) | 2.59121533 |
| 54 | Failure to thrive in infancy (HP:0001531) | 2.57994199 |
| 55 | Spastic gait (HP:0002064) | 2.57715913 |
| 56 | Acute encephalopathy (HP:0006846) | 2.55620079 |
| 57 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.51129169 |
| 58 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.51129169 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.51117832 |
| 60 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.47818968 |
| 61 | Ankle clonus (HP:0011448) | 2.47461653 |
| 62 | Neuroendocrine neoplasm (HP:0100634) | 2.46216154 |
| 63 | Hyperthyroidism (HP:0000836) | 2.46173862 |
| 64 | Poor coordination (HP:0002370) | 2.44979468 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.43583233 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.42833845 |
| 67 | Hemiplegia (HP:0002301) | 2.42252106 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42052657 |
| 69 | Complete atrioventricular canal defect (HP:0001674) | 2.41234950 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.39527925 |
| 71 | Genital tract atresia (HP:0001827) | 2.37852869 |
| 72 | Generalized hypopigmentation of hair (HP:0011358) | 2.36026017 |
| 73 | Vaginal atresia (HP:0000148) | 2.35580505 |
| 74 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.34546637 |
| 75 | Hypoplasia of the brainstem (HP:0002365) | 2.34546637 |
| 76 | Exotropia (HP:0000577) | 2.31995860 |
| 77 | Horizontal nystagmus (HP:0000666) | 2.31661945 |
| 78 | Cortical dysplasia (HP:0002539) | 2.29463721 |
| 79 | Split foot (HP:0001839) | 2.29057647 |
| 80 | Oligomenorrhea (HP:0000876) | 2.27662683 |
| 81 | Short 4th metacarpal (HP:0010044) | 2.26611637 |
| 82 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.26611637 |
| 83 | Genetic anticipation (HP:0003743) | 2.24224567 |
| 84 | Esophageal neoplasm (HP:0100751) | 2.22043162 |
| 85 | Neoplasm of head and neck (HP:0012288) | 2.22043162 |
| 86 | Hypoplasia of the corpus callosum (HP:0002079) | 2.21932662 |
| 87 | Status epilepticus (HP:0002133) | 2.21038966 |
| 88 | Mitochondrial inheritance (HP:0001427) | 2.19025410 |
| 89 | Spastic tetraplegia (HP:0002510) | 2.18871081 |
| 90 | Scanning speech (HP:0002168) | 2.18587129 |
| 91 | Specific learning disability (HP:0001328) | 2.18508603 |
| 92 | Agitation (HP:0000713) | 2.18333594 |
| 93 | Amyotrophic lateral sclerosis (HP:0007354) | 2.15914603 |
| 94 | Dysmetric saccades (HP:0000641) | 2.15053449 |
| 95 | Atrioventricular canal defect (HP:0006695) | 2.11711762 |
| 96 | Narrow nasal bridge (HP:0000446) | 2.07684675 |
| 97 | Retinal dysplasia (HP:0007973) | 2.07608337 |
| 98 | Vitreoretinal degeneration (HP:0000655) | 2.06555244 |
| 99 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.05922555 |
| 100 | Lower limb muscle weakness (HP:0007340) | 2.05455273 |
| 101 | Abnormality of the lower motor neuron (HP:0002366) | 2.05138912 |
| 102 | Fetal akinesia sequence (HP:0001989) | 2.04679800 |
| 103 | Cutaneous finger syndactyly (HP:0010554) | 2.04465666 |
| 104 | Shoulder girdle muscle weakness (HP:0003547) | 2.02857959 |
| 105 | Gait ataxia (HP:0002066) | 1.98785831 |
| 106 | Anxiety (HP:0000739) | 1.98384054 |
| 107 | Medulloblastoma (HP:0002885) | 1.97121805 |
| 108 | Abnormality of salivation (HP:0100755) | 1.96905433 |
| 109 | Generalized myoclonic seizures (HP:0002123) | 1.96422055 |
| 110 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.96389099 |
| 111 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.95442118 |
| 112 | Optic disc pallor (HP:0000543) | 1.94533630 |
| 113 | Leukodystrophy (HP:0002415) | 1.94467650 |
| 114 | Bradykinesia (HP:0002067) | 1.94097007 |
| 115 | Amblyopia (HP:0000646) | 1.92760543 |
| 116 | Akinesia (HP:0002304) | 1.92275421 |
| 117 | Widely spaced teeth (HP:0000687) | 1.91821203 |
| 118 | Increased CSF lactate (HP:0002490) | 1.91389967 |
| 119 | Neuronal loss in central nervous system (HP:0002529) | 1.90845400 |
| 120 | Peripheral hypomyelination (HP:0007182) | 1.90559706 |
| 121 | Abnormality of glycolysis (HP:0004366) | 1.90458855 |
| 122 | Increased serum pyruvate (HP:0003542) | 1.90458855 |
| 123 | Insidious onset (HP:0003587) | 1.88640464 |
| 124 | Termporal pattern (HP:0011008) | 1.88640464 |
| 125 | Delayed gross motor development (HP:0002194) | 1.87411707 |
| 126 | Supranuclear gaze palsy (HP:0000605) | 1.86904040 |
| 127 | Depression (HP:0000716) | 1.86027955 |
| 128 | Generalized hypotonia (HP:0001290) | 1.85980133 |
| 129 | Volvulus (HP:0002580) | 1.85494132 |
| 130 | Limb dystonia (HP:0002451) | 1.83651389 |
| 131 | X-linked dominant inheritance (HP:0001423) | 1.80227966 |
| 132 | Esotropia (HP:0000565) | 1.79727558 |
| 133 | Mutism (HP:0002300) | 1.78980923 |
| 134 | Gastroesophageal reflux (HP:0002020) | 1.78205489 |
| 135 | Postural instability (HP:0002172) | 1.77774902 |
| 136 | Cutaneous syndactyly (HP:0012725) | 1.77592932 |
| 137 | Cortical visual impairment (HP:0100704) | 1.77531023 |
| 138 | Shawl scrotum (HP:0000049) | 1.77333987 |
| 139 | Hammertoe (HP:0001765) | 1.76788360 |
| 140 | Abnormality of the 4th metacarpal (HP:0010012) | 1.74944950 |
| 141 | Renal hypoplasia (HP:0000089) | 1.74058473 |
| 142 | Short tibia (HP:0005736) | 1.73660104 |
| 143 | Neoplasm of the heart (HP:0100544) | 1.73586835 |
| 144 | Inappropriate behavior (HP:0000719) | 1.73521478 |
| 145 | Aqueductal stenosis (HP:0002410) | 1.72991641 |
| 146 | Ulnar claw (HP:0001178) | 1.72887168 |
| 147 | Oligodactyly (hands) (HP:0001180) | 1.71043496 |
| 148 | Neoplasm of the oral cavity (HP:0100649) | 1.70403101 |
| 149 | Papillary thyroid carcinoma (HP:0002895) | 1.70237194 |
| 150 | Tented upper lip vermilion (HP:0010804) | 1.69153450 |
| 151 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.68633171 |
| 152 | Intellectual disability, severe (HP:0010864) | 1.68316916 |
| 153 | Impaired vibratory sensation (HP:0002495) | 1.68124624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 6.24039965 |
| 2 | NTRK3 | 4.37752119 |
| 3 | MAP2K7 | 3.84825793 |
| 4 | ERBB4 | 3.43290033 |
| 5 | MAP3K4 | 3.43015558 |
| 6 | AKT3 | 3.25203791 |
| 7 | MAP3K12 | 3.00637724 |
| 8 | TSSK6 | 2.48129469 |
| 9 | PLK2 | 2.35833120 |
| 10 | PRPF4B | 2.26573188 |
| 11 | MARK1 | 2.21697708 |
| 12 | MAP2K4 | 2.20940816 |
| 13 | PDK4 | 2.10945920 |
| 14 | PDK3 | 2.10945920 |
| 15 | DYRK2 | 2.02530290 |
| 16 | SGK2 | 1.88413330 |
| 17 | MINK1 | 1.82257464 |
| 18 | EPHA3 | 1.78828166 |
| 19 | NTRK2 | 1.71398767 |
| 20 | GRK5 | 1.70596377 |
| 21 | CDK8 | 1.68648860 |
| 22 | TNIK | 1.68144497 |
| 23 | EPHA4 | 1.62599427 |
| 24 | EPHB2 | 1.54027414 |
| 25 | SGK494 | 1.53439403 |
| 26 | SGK223 | 1.53439403 |
| 27 | MUSK | 1.53271454 |
| 28 | PDK2 | 1.40019240 |
| 29 | TYRO3 | 1.33928737 |
| 30 | SIK3 | 1.33041036 |
| 31 | MAP4K2 | 1.29906264 |
| 32 | PRKCE | 1.26083607 |
| 33 | SGK3 | 1.25830672 |
| 34 | PNCK | 1.22813041 |
| 35 | DAPK1 | 1.22692833 |
| 36 | PRKCG | 1.21885809 |
| 37 | NME1 | 1.18522530 |
| 38 | YES1 | 1.17364357 |
| 39 | CDK5 | 1.16038725 |
| 40 | CAMK1G | 1.06420302 |
| 41 | CAMK2A | 1.00219934 |
| 42 | PKN1 | 0.99818208 |
| 43 | MAP3K9 | 0.99211415 |
| 44 | MAPK13 | 0.98341035 |
| 45 | CSNK1A1L | 0.95563946 |
| 46 | CSNK1G3 | 0.94480549 |
| 47 | FES | 0.94126558 |
| 48 | DYRK1A | 0.90651305 |
| 49 | CAMK1D | 0.90482909 |
| 50 | PRKD3 | 0.89821913 |
| 51 | CAMKK2 | 0.88901287 |
| 52 | TAOK1 | 0.88170205 |
| 53 | PAK3 | 0.87507456 |
| 54 | TRIM28 | 0.82833536 |
| 55 | PAK6 | 0.81054918 |
| 56 | PTK2B | 0.78479151 |
| 57 | CSNK1G1 | 0.78460716 |
| 58 | MYLK | 0.77773342 |
| 59 | CCNB1 | 0.72739478 |
| 60 | NTRK1 | 0.70814246 |
| 61 | MAPK15 | 0.70534136 |
| 62 | DYRK3 | 0.69223454 |
| 63 | CAMK2B | 0.68732179 |
| 64 | BCR | 0.67331983 |
| 65 | PRKCH | 0.66553260 |
| 66 | CAMKK1 | 0.64811759 |
| 67 | SIK2 | 0.64121100 |
| 68 | SGK1 | 0.62706628 |
| 69 | BRAF | 0.62658780 |
| 70 | WNK3 | 0.62316755 |
| 71 | CAMK1 | 0.61501727 |
| 72 | ERBB2 | 0.60054528 |
| 73 | DAPK2 | 0.59964681 |
| 74 | ADRBK1 | 0.59447118 |
| 75 | STK16 | 0.57859052 |
| 76 | BMPR1B | 0.57663156 |
| 77 | LATS2 | 0.57318428 |
| 78 | STK11 | 0.56098517 |
| 79 | DYRK1B | 0.55368431 |
| 80 | ADRBK2 | 0.55026837 |
| 81 | ROCK2 | 0.51510446 |
| 82 | BMPR2 | 0.50430786 |
| 83 | PHKG2 | 0.50303527 |
| 84 | PHKG1 | 0.50303527 |
| 85 | GRK6 | 0.49183870 |
| 86 | MATK | 0.49031943 |
| 87 | FGFR2 | 0.48646646 |
| 88 | CAMK4 | 0.48315705 |
| 89 | CAMK2D | 0.47758418 |
| 90 | CSNK1D | 0.47688977 |
| 91 | MAP3K6 | 0.47210631 |
| 92 | PRKACA | 0.45783159 |
| 93 | OXSR1 | 0.45654165 |
| 94 | CDK18 | 0.45337144 |
| 95 | NEK6 | 0.45149775 |
| 96 | PRKCB | 0.44743607 |
| 97 | CAMK2G | 0.44202497 |
| 98 | PLK3 | 0.43217369 |
| 99 | CDK19 | 0.42876179 |
| 100 | BRD4 | 0.41472350 |
| 101 | RIPK4 | 0.41411009 |
| 102 | WNK1 | 0.41298082 |
| 103 | CDK14 | 0.41109919 |
| 104 | UHMK1 | 0.38741503 |
| 105 | KSR1 | 0.38308968 |
| 106 | FGR | 0.38067963 |
| 107 | CDK15 | 0.37952476 |
| 108 | RPS6KA3 | 0.37801711 |
| 109 | FER | 0.37582511 |
| 110 | RET | 0.37346203 |
| 111 | PRKCZ | 0.36798248 |
| 112 | RPS6KB1 | 0.36272845 |
| 113 | MKNK2 | 0.35621114 |
| 114 | PINK1 | 0.32884718 |
| 115 | MAPK10 | 0.31095713 |
| 116 | CSNK1E | 0.31073340 |
| 117 | ERBB3 | 0.31056719 |
| 118 | STK38 | 0.30628034 |
| 119 | CDK3 | 0.30212023 |
| 120 | GSK3B | 0.30180161 |
| 121 | MARK2 | 0.29579656 |
| 122 | CSNK1G2 | 0.29147690 |
| 123 | PRKG1 | 0.28632351 |
| 124 | MAPK4 | 0.28395048 |
| 125 | CDK11A | 0.28225691 |
| 126 | MAPK9 | 0.27974805 |
| 127 | ROCK1 | 0.27319682 |
| 128 | PRKDC | 0.26601461 |
| 129 | MAPK8 | 0.26159527 |
| 130 | PRKACG | 0.25195835 |
| 131 | CSNK1A1 | 0.25065700 |
| 132 | SRC | 0.24978941 |
| 133 | PRKACB | 0.24873012 |
| 134 | FYN | 0.23411727 |
| 135 | PDGFRA | 0.22458700 |
| 136 | DDR2 | 0.22264834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.98788054 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.12388046 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 4.06515978 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.02359342 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 3.15283263 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.52775440 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.50628114 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44438658 |
| 9 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.38802168 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.25858031 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.21397564 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16958841 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.05907453 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.91142900 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.83574704 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.83170679 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79644754 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.76438673 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.73599859 |
| 20 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.71518610 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.70849654 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.70111888 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44369821 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.43946998 |
| 25 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40346240 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35626669 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31110363 |
| 28 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28609932 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.26309166 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25814716 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21782691 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.21163731 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16457746 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.13352776 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.12088274 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06976913 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03356030 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02376920 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99867430 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99635625 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 0.97555711 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97480056 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 0.95079535 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94252276 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93634844 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93408255 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92822641 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92674087 |
| 49 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.91799194 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90897149 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89903830 |
| 52 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.88683817 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83142173 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82111411 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82039005 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82034229 |
| 57 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81053372 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78468837 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77830658 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77706197 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77678614 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75763656 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.73619099 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.72372433 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72303460 |
| 66 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.70459923 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70335586 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.66637207 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64879135 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64648024 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64426537 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62540977 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62354171 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61737681 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61494473 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61149644 |
| 77 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60377295 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.59916671 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58420091 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58001872 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.57013590 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52650725 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52065075 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51566620 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51197230 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51078823 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49810177 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49401691 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48322656 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48070944 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.46402254 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44371919 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43710638 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42588502 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.42242868 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42196489 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41775328 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41506793 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40847984 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40755047 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.40106634 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.40090902 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39514723 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39512664 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.39303854 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39185274 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34857875 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33722067 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33326868 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33093032 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32883088 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32785006 |
| 113 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26684068 |
| 114 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22561652 |
| 115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.18832983 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18762583 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.16744380 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15681039 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.15175800 |
| 120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.15123410 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.13806211 |
| 122 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.13394312 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13235510 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12771764 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.12301223 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12162652 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12090654 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10385703 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.09368764 |

